Allertein Therapeutics, LLC Report issue

For profit Phase 1
Founded: Fairfield CT United States (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2009
NCT00850668
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Food Hypersensitivity (Phase 1)

Hypersensitivity (Phase 1)

Hypersensitivity, Immediate (Phase 1)

Peanut Hypersensitivity (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1